Name: Journey Medical Corporation (DERM) Financial Statements
Creator: FinSpry

Journey Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Journey Medical Corporation income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	56.13	79.18	73.67	63.13	44.53
Cost of Revenue	20.88	22.89	30.78	32.08	14.59
Gross Profit	35.26	56.29	42.89	31.05	29.94
Operating Expenses
Research & Development	9.86	7.54	10.94	2.74	0.00
Selling, General & Administrative	40.20	43.91	59.47	71.92	22.09
Operating Expenses	48.93	55.22	70.41	74.66	22.09
Operating Income	-13.68	1.07	-27.52	-34.88	7.85
Other Income/Expense
Interest Income	0.76	0.32	0.06	0.00	0.00
Interest Expense	2.70	-1.70	-2.02	-7.03	-0.70
Other Income/Expense	-0.93	-3.33	-2.61	0.45	0.00
Income
Income Before Tax	-14.61	-3.63	-29.57	-42.36	7.15
Income Tax Expense	0.06	0.22	0.06	1.63	1.87
Net Income	-14.67	-3.85	-29.63	-43.99	5.28
Net Income - Continuous Operations	-14.67	-3.85	-29.63	-43.99	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-8.40	4.84	-23.24	-30.17	9.28
EBIT	-13.68	1.07	-27.52	-35.33	7.85
Depreciation & Amortization	3.52	3.77	4.28	2.47	1.43
Earnings Per Share
Basic EPS	-1.00	-	-2.00	-4.00	1.00
Diluted EPS	-1.00	-	-2.00	-4.00	-
Basic Shares Outstanding	20.43	18.23	17.53	10.19	9.14
Diluted Shares Outstanding	20.43	18.23	17.53	10.19	10.84